268 related articles for article (PubMed ID: 31487940)
1. Molecular Strategies for RPGR Gene Therapy.
Cehajic Kapetanovic J; McClements ME; Martinez-Fernandez de la Camara C; MacLaren RE
Genes (Basel); 2019 Sep; 10(9):. PubMed ID: 31487940
[TBL] [Abstract][Full Text] [Related]
2. AAV-RPGR Gene Therapy Rescues Opsin Mislocalisation in a Human Retinal Organoid Model of
Sladen PE; Naeem A; Adefila-Ideozu T; Vermeule T; Busson SL; Michaelides M; Naylor S; Forbes A; Lane A; Georgiadis A
Int J Mol Sci; 2024 Feb; 25(3):. PubMed ID: 38339118
[TBL] [Abstract][Full Text] [Related]
3. Codon-Optimized RPGR Improves Stability and Efficacy of AAV8 Gene Therapy in Two Mouse Models of X-Linked Retinitis Pigmentosa.
Fischer MD; McClements ME; Martinez-Fernandez de la Camara C; Bellingrath JS; Dauletbekov D; Ramsden SC; Hickey DG; Barnard AR; MacLaren RE
Mol Ther; 2017 Aug; 25(8):1854-1865. PubMed ID: 28549772
[TBL] [Abstract][Full Text] [Related]
4. Toxicology and Pharmacology of an AAV Vector Expressing Codon-Optimized RPGR in RPGR-Deficient Rd9 Mice.
Song C; Conlon TJ; Deng WT; Coleman KE; Zhu P; Plummer C; Mandapati S; Van Hoosear M; Green KB; Sonnentag P; Sharma AK; Timmers A; Robinson PM; Knop DR; Hauswirth WW; Chulay JD; Shearman MS; Ye GJ
Hum Gene Ther Clin Dev; 2018 Dec; 29(4):188-197. PubMed ID: 30280954
[TBL] [Abstract][Full Text] [Related]
5. Emerging gene therapy products for RPGR-associated X-linked retinitis pigmentosa.
Martinez-Fernandez de la Camara C; Cehajic-Kapetanovic J; MacLaren RE
Expert Opin Emerg Drugs; 2022 Dec; 27(4):431-443. PubMed ID: 36562395
[TBL] [Abstract][Full Text] [Related]
6. Dose Range Finding Studies with Two
Song C; Dufour VL; Cideciyan AV; Ye GJ; Swider M; Newmark JA; Timmers AM; Robinson PM; Knop DR; Chulay JD; Jacobson SG; Aguirre GD; Beltran WA; Shearman MS
Hum Gene Ther; 2020 Jul; 31(13-14):743-755. PubMed ID: 32414297
[TBL] [Abstract][Full Text] [Related]
7. Toxicity and Efficacy Evaluation of an Adeno-Associated Virus Vector Expressing Codon-Optimized
Dufour VL; Cideciyan AV; Ye GJ; Song C; Timmers A; Habecker PL; Pan W; Weinstein NM; Swider M; Durham AC; Ying GS; Robinson PM; Jacobson SG; Knop DR; Chulay JD; Shearman MS; Aguirre GD; Beltran WA
Hum Gene Ther; 2020 Feb; 31(3-4):253-267. PubMed ID: 31910043
[TBL] [Abstract][Full Text] [Related]
8. RPGR gene therapy presents challenges in cloning the coding sequence.
Martinez-Fernandez De La Camara C; Cehajic-Kapetanovic J; MacLaren RE
Expert Opin Biol Ther; 2020 Jan; 20(1):63-71. PubMed ID: 31612744
[No Abstract] [Full Text] [Related]
9. Optimization of Retinal Gene Therapy for X-Linked Retinitis Pigmentosa Due to RPGR Mutations.
Beltran WA; Cideciyan AV; Boye SE; Ye GJ; Iwabe S; Dufour VL; Marinho LF; Swider M; Kosyk MS; Sha J; Boye SL; Peterson JJ; Witherspoon CD; Alexander JJ; Ying GS; Shearman MS; Chulay JD; Hauswirth WW; Gamlin PD; Jacobson SG; Aguirre GD
Mol Ther; 2017 Aug; 25(8):1866-1880. PubMed ID: 28566226
[TBL] [Abstract][Full Text] [Related]
10. Development of a Molecularly Stable Gene Therapy Vector for the Treatment of
Giacalone JC; Andorf JL; Zhang Q; Burnight ER; Ochoa D; Reutzel AJ; Collins MM; Sheffield VC; Mullins RF; Han IC; Stone EM; Tucker BA
Hum Gene Ther; 2019 Aug; 30(8):967-974. PubMed ID: 31106594
[TBL] [Abstract][Full Text] [Related]
11. RPGR: Its role in photoreceptor physiology, human disease, and future therapies.
Megaw RD; Soares DC; Wright AF
Exp Eye Res; 2015 Sep; 138():32-41. PubMed ID: 26093275
[TBL] [Abstract][Full Text] [Related]
12. A long-term efficacy study of gene replacement therapy for RPGR-associated retinal degeneration.
Wu Z; Hiriyanna S; Qian H; Mookherjee S; Campos MM; Gao C; Fariss R; Sieving PA; Li T; Colosi P; Swaroop A
Hum Mol Genet; 2015 Jul; 24(14):3956-70. PubMed ID: 25877300
[TBL] [Abstract][Full Text] [Related]
13. Photoreceptor rescue by an abbreviated human RPGR gene in a murine model of X-linked retinitis pigmentosa.
Pawlyk BS; Bulgakov OV; Sun X; Adamian M; Shu X; Smith AJ; Berson EL; Ali RR; Khani S; Wright AF; Sandberg MA; Li T
Gene Ther; 2016 Feb; 23(2):196-204. PubMed ID: 26348595
[TBL] [Abstract][Full Text] [Related]
14. Gene therapy rescues photoreceptor blindness in dogs and paves the way for treating human X-linked retinitis pigmentosa.
Beltran WA; Cideciyan AV; Lewin AS; Iwabe S; Khanna H; Sumaroka A; Chiodo VA; Fajardo DS; Román AJ; Deng WT; Swider M; Alemán TS; Boye SL; Genini S; Swaroop A; Hauswirth WW; Jacobson SG; Aguirre GD
Proc Natl Acad Sci U S A; 2012 Feb; 109(6):2132-7. PubMed ID: 22308428
[TBL] [Abstract][Full Text] [Related]
15. Association of a Novel Intronic Variant in RPGR With Hypomorphic Phenotype of X-Linked Retinitis Pigmentosa.
Cehajic-Kapetanovic J; McClements ME; Whitfield J; Shanks M; Clouston P; MacLaren RE
JAMA Ophthalmol; 2020 Nov; 138(11):1151-1158. PubMed ID: 32970112
[TBL] [Abstract][Full Text] [Related]
16. A novel mutation in retinitis pigmentosa GTPase regulator gene with a distinctive retinitis pigmentosa phenotype in a Chinese family.
Sheng X; Li Z; Zhang X; Wang J; Ren H; Sun Y; Meng R; Rong W; Zhuang W
Mol Vis; 2010 Aug; 16():1620-8. PubMed ID: 20806050
[TBL] [Abstract][Full Text] [Related]
17. Multiprotein complexes of Retinitis Pigmentosa GTPase regulator (RPGR), a ciliary protein mutated in X-linked Retinitis Pigmentosa (XLRP).
Murga-Zamalloa C; Swaroop A; Khanna H
Adv Exp Med Biol; 2010; 664():105-14. PubMed ID: 20238008
[TBL] [Abstract][Full Text] [Related]
18. Disease mechanisms of X-linked retinitis pigmentosa due to RP2 and RPGR mutations.
Lyraki R; Megaw R; Hurd T
Biochem Soc Trans; 2016 Oct; 44(5):1235-1244. PubMed ID: 27911705
[TBL] [Abstract][Full Text] [Related]
19. Gene therapy for the treatment of X-linked retinitis pigmentosa.
Martinez-Fernandez De La Camara C; Nanda A; Salvetti AP; Fischer MD; MacLaren RE
Expert Opin Orphan Drugs; 2018 Feb; 6(3):167-177. PubMed ID: 30057863
[TBL] [Abstract][Full Text] [Related]
20. In Vivo CRISPR/Cas9-Mediated Genome Editing Mitigates Photoreceptor Degeneration in a Mouse Model of X-Linked Retinitis Pigmentosa.
Hu S; Du J; Chen N; Jia R; Zhang J; Liu X; Yang L
Invest Ophthalmol Vis Sci; 2020 Apr; 61(4):31. PubMed ID: 32330228
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
